The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a disease severity index to help prioritize allocation of organs for transplant.
Mayo Clinic researchers published the original MELD model in 2001. Refinements have been developed since then. These models are for use by medical professionals.
See other mathematical models for liver disease patients: